Literature DB >> 16785446

The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.

Jae Jin Chae1, Geryl Wood, Seth L Masters, Katharina Richard, Grace Park, Brian J Smith, Daniel L Kastner.   

Abstract

Familial Mediterranean fever (FMF) is a recessively inherited autoinflammatory disorder with high carrier frequencies in the Middle East. Pyrin, the protein mutated in FMF, regulates caspase-1 activation and consequently IL-1beta production through cognate interaction of its N-terminal PYRIN motif with the ASC adaptor protein. However, the preponderance of mutations reside in pyrin's C-terminal B30.2 domain. Here we demonstrate direct interaction of this domain with caspase-1. In lysates from cells not expressing ASC, reciprocal GST pull-downs demonstrated the interaction of pyrin with the p20 and p10 catalytic subunits of caspase-1. Coimmunoprecipitations of pyrin and caspase-1 from THP-1 human monocytic cells were consistent with the interaction of endogenous proteins. The C-terminal B30.2 domain of pyrin is necessary and sufficient for the interaction, and binding was reduced by FMF-associated B30.2 mutations. Full-length pyrin attenuated IL-1beta production in cells transfected with a caspase-1/IL-1beta construct, an effect diminished by FMF-associated B30.2 mutations and in B30.2 deletion mutants. Modeling of the crystal structure of caspase-1 with the deduced structure of the pyrin B30.2 domain corroborated both the interaction and the importance of M694V and M680I pyrin mutations. Consistent with a net inhibitory effect of pyrin on IL-1beta activation, small interfering RNA (siRNA)-mediated pyrin knockdown in THP-1 cells augmented IL-1beta production in response to bacterial LPS. Moreover, the IL-1 receptor antagonist anakinra suppressed acute-phase proteins in a patient with FMF and amyloidosis. Our data support a direct, ASC-independent effect of pyrin on IL-1beta activation and suggest heightened IL-1 responsiveness as one factor selecting for pyrin mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785446      PMCID: PMC1479864          DOI: 10.1073/pnas.0602081103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells.

Authors:  J Masumoto; S Taniguchi; K Ayukawa; H Sarvotham; T Kishino; N Niikawa; E Hidaka; T Katsuyama; T Higuchi; J Sagara
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

2.  RDOCK: refinement of rigid-body protein docking predictions.

Authors:  Li Li; Rong Chen; Zhiping Weng
Journal:  Proteins       Date:  2003-11-15

3.  ZDOCK: an initial-stage protein-docking algorithm.

Authors:  Rong Chen; Li Li; Zhiping Weng
Journal:  Proteins       Date:  2003-07-01

4.  Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis.

Authors:  Jae Jin Chae; Hirsh D Komarow; Jun Cheng; Geryl Wood; Nina Raben; P Paul Liu; Daniel L Kastner
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

5.  Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1.

Authors:  Nam Jin Yoo; Won Sang Park; Su Young Kim; John C Reed; Seong Gon Son; Jung Young Lee; Sug Hyung Lee
Journal:  Biochem Biophys Res Commun       Date:  2002-12-13       Impact factor: 3.575

6.  The PYRIN-CARD protein ASC is an activating adaptor for caspase-1.

Authors:  Srinivasa M Srinivasula; Jean-Luc Poyet; Marjaneh Razmara; Pinaki Datta; ZhiJia Zhang; Emad S Alnemri
Journal:  J Biol Chem       Date:  2002-04-19       Impact factor: 5.157

7.  Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product.

Authors:  Theresa A Dowds; Junya Masumoto; Felicia F Chen; Yasunori Ogura; Naohiro Inohara; Gabriel Núñez
Journal:  Biochem Biophys Res Commun       Date:  2003-03-14       Impact factor: 3.575

8.  ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis.

Authors:  Junya Masumoto; Theresa A Dowds; Philip Schaner; Felicia F Chen; Yasunori Ogura; Mu Li; Li Zhu; Tsutomu Katsuyama; Junji Sagara; Shun'ichiro Taniguchi; Deborah L Gumucio; Gabriel Núñez; Naohiro Inohara
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

9.  Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation.

Authors:  Christian Stehlik; Sug Hyung Lee; Andrea Dorfleutner; Angela Stassinopoulos; Junji Sagara; John C Reed
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

10.  The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways.

Authors:  Christian Stehlik; Loredana Fiorentino; Andrea Dorfleutner; Jean-Marie Bruey; Eugenia M Ariza; Junji Sagara; John C Reed
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

View more
  170 in total

Review 1.  Inflammasome-mediated autoinflammatory disorders.

Authors:  Shruti P Wilson; Suzanne L Cassel
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

Review 2.  Autoinflammatory Syndromes in Children.

Authors:  Ruth J Pepper; Helen J Lachmann
Journal:  Indian J Pediatr       Date:  2016-01-29       Impact factor: 1.967

Review 3.  Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes.

Authors:  V U Ozkurede; L Franchi
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 4.  IL-1 pathways in inflammation and human diseases.

Authors:  Cem Gabay; Céline Lamacchia; Gaby Palmer
Journal:  Nat Rev Rheumatol       Date:  2010-02-23       Impact factor: 20.543

5.  Decrease in the rate of secondary amyloidosis in Turkish children with FMF: are we doing better?

Authors:  Victoria Akse-Onal; Erdal Sağ; Seza Ozen; Aysin Bakkaloglu; Nilgun Cakar; Nesrin Besbas; Safak Gucer
Journal:  Eur J Pediatr       Date:  2010-02-24       Impact factor: 3.183

Review 6.  COPs and POPs: modulators of inflammasome activity.

Authors:  Christian Stehlik; Andrea Dorfleutner
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

Review 7.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

8.  Characterization of Pyrin Dephosphorylation and Inflammasome Activation in Macrophages as Triggered by the Yersinia Effectors YopE and YopT.

Authors:  Natasha P Medici; Maheen Rashid; James B Bliska
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

Review 9.  IL-1β biological treatment of familial Mediterranean fever.

Authors:  Alessandra Soriano; Elena Verecchia; Antonella Afeltra; Raffaele Landolfi; Raffaele Manna
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

10.  Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease.

Authors:  Yelda Bilginer; Nuray Aktay Ayaz; Seza Ozen
Journal:  Clin Rheumatol       Date:  2009-09-23       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.